Year |
Citation |
Score |
2024 |
Jubran J, Slutsky R, Rozenblum N, Rokach L, Ben-David U, Yeger-Lotem E. Machine-learning analysis reveals an important role for negative selection in shaping cancer aneuploidy landscapes. Genome Biology. 25: 95. PMID 38622679 DOI: 10.1186/s13059-024-03225-7 |
0.363 |
|
2024 |
Nair NU, Schäffer AA, Gertz EM, Cheng K, Zerbib J, Sahu AD, Leor G, Shulman ED, Aldape KD, Ben-David U, Ruppin E. Chromosome 7 to the rescue: overcoming chromosome 10 loss in gliomas. Biorxiv : the Preprint Server For Biology. PMID 38313282 DOI: 10.1101/2024.01.17.576103 |
0.4 |
|
2023 |
Chang TG, Cao Y, Shulman ED, Ben-David U, Schäffer AA, Ruppin E. Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations. Npj Precision Oncology. 7: 54. PMID 37270587 DOI: 10.1038/s41698-023-00408-6 |
0.33 |
|
2023 |
Prasad K, Ben-David U. A balancing act: how whole-genome doubling and aneuploidy interact in human cancer. Oncotarget. 14: 382-383. PMID 37185141 DOI: 10.18632/oncotarget.28374 |
0.374 |
|
2023 |
Garribba L, De Feudis G, Martis V, Galli M, Dumont M, Eliezer Y, Wardenaar R, Ippolito MR, Iyer DR, Tijhuis AE, Spierings DCJ, Schubert M, Taglietti S, Soriani C, Gemble S, ... ... Ben-David U, et al. Short-term molecular consequences of chromosome mis-segregation for genome stability. Nature Communications. 14: 1353. PMID 36906648 DOI: 10.1038/s41467-023-37095-7 |
0.412 |
|
2022 |
Hoge ACH, Getz M, Zimmer A, Ko M, Raz L, Beroukhim R, Golub TR, Ha G, Ben-David U. Publisher Correction: DNA-based copy number analysis confirms genomic evolution of PDX models. Npj Precision Oncology. 6: 50. PMID 35821277 DOI: 10.1038/s41698-022-00293-5 |
0.56 |
|
2022 |
Prasad K, Bloomfield M, Levi H, Keuper K, Bernhard SV, Baudoin NC, Leor G, Eliezer Y, Giam M, Wong CK, Rancati G, Storchová Z, Cimini D, Ben-David U. Whole-Genome Duplication Shapes the Aneuploidy Landscape of Human Cancers. Cancer Research. 82: 1736-1752. PMID 35502547 DOI: 10.1158/0008-5472.CAN-21-2065 |
0.357 |
|
2021 |
Ippolito MR, Martis V, Martin S, Tijhuis AE, Hong C, Wardenaar R, Dumont M, Zerbib J, Spierings DCJ, Fachinetti D, Ben-David U, Foijer F, Santaguida S. Gene copy-number changes and chromosomal instability induced by aneuploidy confer resistance to chemotherapy. Developmental Cell. PMID 34352223 DOI: 10.1016/j.devcel.2021.07.006 |
0.355 |
|
2021 |
Wang RW, Viganò S, Ben-David U, Amon A, Santaguida S. Aneuploid senescent cells activate NF-κB to promote their immune clearance by NK cells. Embo Reports. e52032. PMID 34105235 DOI: 10.15252/embr.202052032 |
0.308 |
|
2021 |
Cohen-Sharir Y, McFarland JM, Abdusamad M, Marquis C, Bernhard SV, Kazachkova M, Tang H, Ippolito MR, Laue K, Zerbib J, Malaby HLH, Jones A, Stautmeister LM, Bockaj I, Wardenaar R, ... ... Ben-David U, et al. Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition. Nature. PMID 33505028 DOI: 10.1038/s41586-020-03114-6 |
0.666 |
|
2020 |
Rendo V, Enache OM, Ben-David U. Adding to the CASeload: unwarranted p53 signaling induced by Cas9. Molecular & Cellular Oncology. 7: 1789419. PMID 32944644 DOI: 10.1080/23723556.2020.1789419 |
0.311 |
|
2020 |
Corsello SM, Nagari RT, Spangler RD, Rossen J, Kocak M, Bryan JG, Humeidi R, Peck D, Wu X, Tang AA, Wang VM, Bender SA, Lemire E, Narayan R, Montgomery P, ... Ben-David U, et al. Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling. Nature Cancer. 1: 235-248. PMID 32613204 DOI: 10.1038/s43018-019-0018-6 |
0.597 |
|
2020 |
Enache OM, Rendo V, Abdusamad M, Lam D, Davison D, Pal S, Currimjee N, Hess J, Pantel S, Nag A, Thorner AR, Doench JG, Vazquez F, Beroukhim R, Golub TR, ... Ben-David U, et al. Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations. Nature Genetics. PMID 32587373 DOI: 10.1038/S41588-020-0663-9 |
0.506 |
|
2020 |
Enache OM, Rendo V, Abdusamad M, Lam D, Davison D, Pal S, Currimjee N, Hess J, Pantel S, Nag A, Thorner AR, Doench JG, Vazquez F, Beroukhim R, Golub TR, ... Ben-David U, et al. Cas9 activates the p53 pathway and selects for p53-inactivating mutations. Nature Genetics. PMID 32424350 DOI: 10.1038/S41588-020-0623-4 |
0.635 |
|
2020 |
Corsello SM, Nagari RT, Spangler RD, Rossen J, Kocak M, Bryan JG, Humeidi R, Peck D, Wu X, Tang AA, Wang VM, Bender SA, Lemire E, Narayan R, Montgomery P, ... Ben-David U, et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling Nature Cancer. 1: 235-248. DOI: 10.1038/s43018-019-0018-6 |
0.41 |
|
2019 |
Ben-David U, Amon A. Context is everything: aneuploidy in cancer. Nature Reviews. Genetics. PMID 31548659 DOI: 10.1038/S41576-019-0171-X |
0.407 |
|
2018 |
Ben-David U, Beroukhim R, Golub TR. Genomic evolution of cancer models: perils and opportunities. Nature Reviews. Cancer. PMID 30578414 DOI: 10.1038/S41568-018-0095-3 |
0.65 |
|
2018 |
Ben-David U, Siranosian B, Ha G, Tang H, Oren Y, Hinohara K, Strathdee CA, Dempster J, Lyons NJ, Burns R, Nag A, Kugener G, Cimini B, Tsvetkov P, Maruvka YE, et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature. PMID 30089904 DOI: 10.1038/S41586-018-0409-3 |
0.714 |
|
2018 |
Abdeen SK, Ben-David U, Shweiki A, Maly B, Aqeilan RI. Somatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer. Cell Death & Disease. 9: 832. PMID 30082886 DOI: 10.1038/s41419-018-0896-z |
0.314 |
|
2018 |
Ben-David U, Siranosian B, Ha G, Tang H, Lyons NJ, Burns R, Nag A, Cimini B, Tsvetkov P, Tubelli AA, Wong B, Thorner AR, Bittker J, Meyerson M, Beroukhim R, et al. Abstract 214: Genetic and transcriptional instability alters cell line drug response Cancer Research. 78: 214-214. DOI: 10.1158/1538-7445.Am2018-214 |
0.674 |
|
2018 |
Ben-David U, Ha G, Tseng Y, Greenwald NF, Oh C, Shih J, McFarland JM, Wong B, Boehm JS, Beroukhim R, Golub TR. Abstract 1028: Patient-derived xenografts undergo mouse-specific tumor evolution Tumor Biology. DOI: 10.1158/1538-7445.Am2018-1028 |
0.424 |
|
2017 |
Ben-David U, Ha G, Tseng YY, Greenwald NF, Oh C, Shih J, McFarland JM, Wong B, Boehm JS, Beroukhim R, Golub TR. Patient-derived xenografts undergo mouse-specific tumor evolution. Nature Genetics. PMID 28991255 DOI: 10.1038/Ng.3967 |
0.641 |
|
2016 |
Bi WL, Horowtiz P, Greenwald N, Abedalthagafi M, Agarwalla PK, Gibson WJ, Mei Y, Schumacher SE, Ben-David U, Chevalier A, Carter SL, Tiao G, Brastianos PK, Ligon AH, Ducar M, et al. Landscape of genomic alterations in pituitary adenomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27707790 DOI: 10.1158/1078-0432.Ccr-16-0790 |
0.584 |
|
2016 |
Ben-David U, Ha G, Khadka P, Jin X, Wong B, Franke L, Golub TR. The landscape of chromosomal aberrations in breast cancer mouse models reveals driver-specific routes to tumorigenesis. Nature Communications. 7: 12160. PMID 27374210 DOI: 10.1038/Ncomms12160 |
0.63 |
|
2016 |
Aguirre AJ, Meyers RM, Weir BA, Vazquez F, Zhang CZ, Ben-David U, Cook A, Ha G, Harrington WF, Doshi MB, Kost-Alimova M, Gill S, Xu H, Ali LD, Jiang G, et al. Genomic copy number dictates a gene-independent cell response to CRISPR-Cas9 targeting. Cancer Discovery. PMID 27260156 DOI: 10.1158/2159-8290.Cd-16-0154 |
0.613 |
|
2016 |
Ben-David U, Ha G, Khadka P, Jin X, Franke L, Golub TR. The landscape of chromosomal aberrations in mouse models of breast cancer reveals driver-specific routes to tumor development Cancer Research. 76: 2683-2683. DOI: 10.1158/1538-7445.Am2016-2683 |
0.466 |
|
2015 |
Ben-David U. Genomic instability, driver genes and cell selection: Projections from cancer to stem cells. Biochimica Et Biophysica Acta. 1849: 427-35. PMID 25132386 DOI: 10.1016/j.bbagrm.2014.08.005 |
0.351 |
|
2014 |
Ben-David U, Arad G, Weissbein U, Mandefro B, Maimon A, Golan-Lev T, Narwani K, Clark AT, Andrews PW, Benvenisty N, Carlos Biancotti J. Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells. Nature Communications. 5: 4825. PMID 25198699 DOI: 10.1038/Ncomms5825 |
0.318 |
|
2014 |
Ben-David U, Biran A, Scaffidi P, Herold-Mende C, Boehringer M, Meshorer E, Benvenisty N. Elimination of undifferentiated cancer cells by pluripotent stem cell inhibitors. Journal of Molecular Cell Biology. 6: 267-9. PMID 24683201 DOI: 10.1093/Jmcb/Mju012 |
0.331 |
|
2013 |
Ben-David U, Mayshar Y, Benvenisty N. Virtual karyotyping of pluripotent stem cells on the basis of their global gene expression profiles. Nature Protocols. 8: 989-97. PMID 23619890 DOI: 10.1038/Nprot.2013.051 |
0.304 |
|
2012 |
Ben-David U, Benvenisty N. High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cells. Stem Cells (Dayton, Ohio). 30: 612-22. PMID 22328490 DOI: 10.1002/Stem.1057 |
0.317 |
|
2010 |
Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT, Plath K, Lowry WE, Benvenisty N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell. 7: 521-31. PMID 20887957 DOI: 10.1016/J.Stem.2010.07.017 |
0.332 |
|
Show low-probability matches. |